Sort   by:  
 Page size 
UnknownBaseline OCT measurements in the idiopathic intracranial hypertension treatment trial, part II: correlations and relationship to clinical features.
Not available
S-EPMC4266073 | biostudies-literature
UnknownBaseline OCT measurements in the idiopathic intracranial hypertension treatment trial, part I: quality control, comparisons, and variability.
Not available
S-EPMC4266084 | biostudies-literature
UnknownEffect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial.
Not available
S-EPMC4362615 | biostudies-literature
UnknownVisual Field Outcomes for the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT).
Not available
S-EPMC4777274 | biostudies-literature
UnknownRisk factors for poor visual outcome in patients with idiopathic intracranial hypertension.
Not available
S-EPMC4553022 | biostudies-literature
UnknownEfficacy and Safety of Degludec versus Glargine in Type 2 Diabetes.
Not available
S-EPMC5731244 | biostudies-literature
Unknown'Matching Michigan': a 2-year stepped interventional programme to minimise central venous catheter-blood stream infections in intensive care units in England.
Not available
S-EPMC3585494 | biostudies-literature
UnknownPlasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer: the STAMPEDE Phase 3 Randomized Clinical Trial.
Not available
S-EPMC11869088 | biostudies-literature
UnknownMetformin for patients with metastatic prostate cancer starting androgen deprivation therapy: a randomised phase 3 trial of the STAMPEDE platform protocol.
Not available
S-EPMC12303861 | biostudies-literature
Sort   by:  
 Page size